NSE BSE
bharat immunologicals & biolog stock

BHARAT IMMUNOLOGICALS & BIOLOG Share Price

- - (%)
- NSE: BIBCL

BHARAT IMMUNOLOGICALS & BIOLOG Share Price Update

As of the latest trading session, BHARAT IMMUNOLOGICALS & BIOLOG share price is currently at 28.8, which is down by -0.28 from its previous closing. Today, the stock has fluctuated between 27.75 and 29.50. Over the past year, BHARAT IMMUNOLOGICALS & BIOLOG has achieved a return of 31.58 %. In the last month alone, the return has been -7.91 %. Read More...

BHARAT IMMUNOLOGICALS & BIOLOG Performance

Day Range

Low27.75 High29.50
28.80

52 Week Range

Low 21.00 High 43.89
28.80

BHARAT IMMUNOLOGICALS & BIOLOG Share Price

524663

BIBCL

img img img img
No Data Available

Open Price

29.50

Prev. Close

29.08

Volume (Shares)

85123.00

Total traded value

24.51

Upper Circuit

.00

Lower Circuit

.00

Note: The current prices & values are delayed, Login to your account for live updates.

BHARAT IMMUNOLOGICALS & BIOLOG Fundamentals


(Standalone)

Market Cap (Cr) 124.80
PE Ratio (TTM) 0.00
Book Value / Share -7.53
Beta 0.91
ROE 0.00%
EPS (TTM) 0.00
Dividend Yield 0.00%
Net Profit Qtr (Cr) -4.92

BHARAT IMMUNOLOGICALS & BIOLOG Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition

Revenue

Net income

Particulars SEP 2023 (Values in Cr)
Revenue 0.00
Operating Expense 6.81
Net Profit -4.92
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) -1.14
EBITDA -4.53
Effective Tax Rate (%) 26.01
Particulars JUN 2023 (Values in Cr)
Revenue 0.00
Operating Expense 6.06
Net Profit -4.59
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) -1.06
EBITDA -4.22
Effective Tax Rate (%) 23.11
Particulars MAR 2023 (Values in Cr)
Revenue 7.65
Operating Expense 13.82
Net Profit -3.88
Net Profit Margin (%) -50.71
Earnings Per Share (EPS) -0.90
EBITDA -3.53
Effective Tax Rate (%) 31.69
Particulars DEC 2022 (Values in Cr)
Revenue 0.00
Operating Expense 6.43
Net Profit -4.68
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) -1.08
EBITDA -4.62
Effective Tax Rate (%) 26.06
Particulars SEP 2022 (Values in Cr)
Revenue 26.48
Operating Expense 30.75
Net Profit -3.08
Net Profit Margin (%) -11.63
Earnings Per Share (EPS) -0.71
EBITDA -2.17
Effective Tax Rate (%) 22.22
Particulars MAR 2023 (Values in Cr)
Revenue 44.61
Operating Expense 67.94
Net Profit -16.64
Net Profit Margin (%) -37.30
Earnings Per Share (EPS) -3.85
EBITDA -15.02
Effective Tax Rate (%) 25.28
Particulars MAR 2022 (Values in Cr)
Revenue 78.39
Operating Expense 89.18
Net Profit -8.75
Net Profit Margin (%) -11.16
Earnings Per Share (EPS) -2.03
EBITDA -3.88
Effective Tax Rate (%) 9.59
Particulars MAR 2021 (Values in Cr)
Revenue 85.33
Operating Expense 111.22
Net Profit -18.11
Net Profit Margin (%) -21.22
Earnings Per Share (EPS) 1.10
EBITDA -19.19
Effective Tax Rate (%) 25.19
Particulars MAR 2020 (Values in Cr)
Revenue 66.84
Operating Expense 82.22
Net Profit -10.21
Net Profit Margin (%) -15.27
Earnings Per Share (EPS) -2.36
EBITDA -9.21
Effective Tax Rate (%) 28.09
Particulars MAR 2019 (Values in Cr)
Revenue 83.65
Operating Expense 95.24
Net Profit -5.79
Net Profit Margin (%) -6.92
Earnings Per Share (EPS) -1.57
EBITDA -5.09
Effective Tax Rate (%) 21.43
Particulars MAR 2023 (Values in Cr)
Book Value / Share -5.43
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.00
EBITDA Margin -35.10
Particulars MAR 2022 (Values in Cr)
Book Value / Share -1.48
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.00
EBITDA Margin -4.94
Particulars MAR 2021 (Values in Cr)
Book Value / Share 0.55
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 1.33
EBITDA Margin -22.48
Particulars MAR 2020 (Values in Cr)
Book Value / Share 4.74
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.69
EBITDA Margin -13.79
Particulars MAR 2019 (Values in Cr)
Book Value / Share 7.10
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.47
EBITDA Margin -6.10
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 8.73
Total Assets 185.66
Total Liabilities 185.66
Total Equity 87.79
Share Outstanding 43180000
Price to Book Ratio -4.09
Return on Assets (%) -9.18
Return on Capital (%) -10.79
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 13.00
Total Assets 212.72
Total Liabilities 212.72
Total Equity 105.35
Share Outstanding 43180000
Price to Book Ratio -18.99
Return on Assets (%) -4.11
Return on Capital (%) -4.78
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 10.53
Total Assets 103.98
Total Liabilities 103.98
Total Equity 34.04
Share Outstanding 43180000
Price to Book Ratio 82.73
Return on Assets (%) -17.41
Return on Capital (%) -29.53
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 12.09
Total Assets 126.82
Total Liabilities 126.82
Total Equity 20.47
Share Outstanding 43180000
Price to Book Ratio 1.23
Return on Assets (%) -8.05
Return on Capital (%) -43.43
Particulars MAR 2019 (Values in Cr)
Cash & Short Term Investments 7.93
Total Assets 124.96
Total Liabilities 124.96
Total Equity 30.67
Share Outstanding 43180000
Price to Book Ratio 1.08
Return on Assets (%) -4.63
Return on Capital (%) -9.21
Particulars MAR 2023 (Values in Cr)
Net Income -22.85
Cash from Operations 10.88
Cash from Investing 0.46
Cash from Financing -14.70
Net change in Cash -3.35
Free Cash Flow 10.88
Particulars MAR 2022 (Values in Cr)
Net Income -9.68
Cash from Operations -42.11
Cash from Investing 0.53
Cash from Financing 45.00
Net change in Cash 3.41
Free Cash Flow -42.11
Particulars MAR 2021 (Values in Cr)
Net Income -24.20
Cash from Operations 11.77
Cash from Investing 0.66
Cash from Financing -12.20
Net change in Cash 0.24
Free Cash Flow 11.77
Particulars MAR 2020 (Values in Cr)
Net Income -14.20
Cash from Operations 34.07
Cash from Investing 0.91
Cash from Financing -34.41
Net change in Cash 0.57
Free Cash Flow 34.07
Particulars MAR 2019 (Values in Cr)
Net Income -7.37
Cash from Operations -32.09
Cash from Investing 0.69
Cash from Financing 30.70
Net change in Cash -0.69
Free Cash Flow -32.07
Company Name Price P/E P/B Market Cap 52 Week Low/High
BLISS GVS PHARMA LTD 116.00 12.68 1.25 1214.96 77.65 / 148.95
CIPLA LTD 1516.05 28.75 4.58 122423.77 1020.00 / 1581.70
FERMENTA BIOTECH LIMITED 200.05 0.00 2.03 588.77 136.60 / 219.05
GLAXOSMITHKLINE PHARMA LT 2552.80 65.86 24.32 43245.97 1376.50 / 2759.00
SANOFI INDIA LIMITED 6457.95 26.22 14.64 14872.66 5850.55 / 10526.05
Company Name Price P/E P/B Market Cap 52 Week Low/High
BHARAT IMMUNOLOGICALS & BIOLOG 29.08 0.00 -3.85 125.57 21.00 / 43.89
AMRUTAJAN HEALTH LTD 744.70 47.86 7.46 2152.97 556.05 / 826.00
ASTRAZENECA PHARMA IND LT 6625.00 110.79 23.26 16562.50 3715.05 / 7550.00
BLISS GVS PHARMA LTD 116.00 15.96 1.22 1214.96 77.65 / 148.95
ABBOTT INDIA LIMITED 28590.80 50.58 16.42 60755.45 21907.45 / 29628.15

Technicals

  • EMA & SMA
  • Resistance and Support
  • Price Change Analysis
- redarrow -
red-green-graph indicator
Bullish Moving Averages -
Bearish Moving Averages -
  • 5 Days 28.90
  • 26 Days 29.20
  • 10 Days 28.90
  • 50 Days 29.60
  • 12 Days 29.00
  • 100 Days 30.60
  • 20 Days 29.40
  • 200 Days 24.90
29.13
PIVOT
First Resistance 29.45
Second Resistance 29.83
Third Resistance 30.15
First Support 28.75
Second Support 28.43
Third Support 28.05
RSI 45.94
MACD -0.21
Commodity Channel Index (CCI) -35.93
ADX 12.62
Williams % R -50.00

Over 1 Month

down

-7.91

Over 3 Months

down

-4.08

Over 6 Months

down

-14.31

Over 1 Year

down

31.58

Over 3 Years

down

-23.82

Over 5 Years

down

33.76

BHARAT IMMUNOLOGICALS & BIOLOG Future

Future: Price

25 May
0 100 200 300 400 500 600

Discount/Premium

25 May
0 1 2 3 4 5 6 7

Active Calls

25 May
0 500 1000 1500 2000 2500 3000

Active Puts

25 Jul
0 500 1000 1500 2000 2500

BHARAT IMMUNOLOGICALS & BIOLOG Shareholding Pattern

  • Shareholding Summary
  • Historical Promotor Holding
  • Historical MF Holding
  • Historical FII Holding

Holding

Others
40.74
Promoter Holdings
59.25
FII
0.0
DII
0.0
Promoter Shares(Pledge Percentage)
0.0
Name Category Shares Shares%
President Of India Shareholding of Promoter and Promoter Group 2.5585993E7 59.25
Sh Pankaj Upadhyay, Ds, Dbt Shareholding of Promoter and Promoter Group 1.0 0.0
Dr Nitin K Jain, Scientist G, Dbt Shareholding of Promoter and Promoter Group 1.0 0.0
Dr Dhananjay Tiwary, Scientist G, Dbt Shareholding of Promoter and Promoter Group 1.0 0.0
Dr Alka Sharma, Scientist H, Dbt Shareholding of Promoter and Promoter Group 1.0 0.0
Dr Sanjay Mishra, Scientist H, Dbt Shareholding of Promoter and Promoter Group 1.0 0.0
Sh Vishwajit Sahay As&fa, Dbt Shareholding of Promoter and Promoter Group 1.0 0.0
Dr Rajesh S Gokhale, Secretary Dbt Shareholding of Promoter and Promoter Group 1.0 0.0

BHARAT IMMUNOLOGICALS & BIOLOG

  • Dividend
  • Bonus
  • Split
Ex-Date Dividend Amt. Dividend Type Record Date Instrument Type
Ex-Date Ex-Bonus Ratio
Ex-Date Old FV NEW FV Record Date

Learn More About Stocks

About BHARAT IMMUNOLOGICALS & BIOLOG

Read More
  • Management structure
  • Board of directors
  • Committees of the board of directors

Companies Owned by BHARAT IMMUNOLOGICALS & BIOLOG

We have something for everyone

Explore More Investment Options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 5x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Frequently Asked Questions

What is the Share Price of Bharat Immunological & Biological Corporation Ltd?

Answer Field

The share price of Bharat Immunological & Biological Corporation Ltd for NSE is ₹ 0.00 and for BSE is ₹ 28.90.

What is the Market Cap of Bharat Immunological & Biological Corporation Ltd?

Answer Field

The market cap of Bharat Immunological & Biological Corporation Ltd for NSE is ₹ 0.0 Cr. and for BSE is ₹ 124.80 Cr. as of now.

What is the 52 Week High and Low of Bharat Immunological & Biological Corporation Ltd?

Answer Field

The 52 Week High and Low of Bharat Immunological & Biological Corporation Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 43.89 and ₹ 21.00.

How to Buy Bharat Immunological & Biological Corporation Ltd share?

Answer Field

You can trade in Bharat Immunological & Biological Corporation Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Bharat Immunological & Biological Corporation Ltd?

Answer Field

The 1 year returns on the stock has been 31.58%.

No results found

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

7.5 Lacs+ Users

icon-with-text

4.3+ App Rating

icon-with-text

4 Languages

icon-with-text

₹4300 Cr MTF Book

icon-with-text
loader